We work with companies in a number of ways, including the delivery of commercially sponsored studies.
Learn more about how we can help you to achieve your goals below.
Clinical trials
We have a comprehensive research infrastructure, robust processes, diverse patient cohorts and the experience of managing commercially led clinical trials.
Access to clinical expertise and facilities
Working with our Innovation Management Service, TRUSTECH, we provide a range of commercial consultancy services to help UK and international companies develop medicines and vaccines, medical devices and equipment, diagnostics and screening tools, education and training materials, and software and information services:
- Market research
- Business case development
- Proof of market studies
- Clinical validations
- Project management
To learn more about accessing clinical expertise and facilities please contact Rebecca Ryan, TRUSTECH Administration Manager, via email: innovations@trustech.org.uk
Licencing NHS Intellectual Property (IP) to develop new healthcare products
Manchester Health Ventures (MHV), manages and develops our valuable intellectual and commercial assets, including our contract with TRUSTECH, the NHS Innovation Service. To learn more about opportunities to licence MFT intellectual property and co-develop innovative medical technologies, please contact mft.innovation@mft.nhs.uk (+44(0)161 276 8631). If you are a MFT employee requiring innovation management advice, please contact TRUSTECH, our innovation management service provider via email: innovations@trustech.org.uk
Accommodation and support on the largest clinical-academic campus in Europe
Our collaboration with Manchester Science Partnerships (MSP), Citylabs provides accommodation for biomedical companies on our hospital site, plus access to clinical expertise to inform understanding of market need and develop/trial new diagnostics and devices. Through the MedTech Centre Incubator, the partnership can also provide accommodation and support to smaller companies and innovators developing technology, which will help the NHS to provide high-quality, efficient care to its patients.
